Study to Evaluate the Effect of the Treatment With Micardis® or MicardisPlus® on Blood Pressure
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary objective was to evaluate the effect of the treatment with Micardis® or
MicardisPlus® on blood pressure. Secondary objectives were the effect of Micardis® /
MicardisPlus® on metabolic parameters (triglycerides, cholesterol, LDL blood glucose, insulin
Homeostasis Model Assessment (HOMA)-index and HbA1c) in patients with essential hypertension
and diabetes mellitus
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Hydrochlorothiazide Telmisartan Telmisartan, hydrochlorothiazide drug combination